Hi there!
We track 52,000+ AI startups and surface hidden job opportunities that never appear on LinkedIn. Tell us what you're looking for, our AI agent does the searching. It's free and you sign up using Google. Go explore!
Biomia
Biomia is a preclinical-stage synthetic biology company focused on developing novel small molecule therapeutics inspired by nature to treat central nervous system (CNS) disorders such as pain, mental…
Biomia
Biomia is a preclinical-stage synthetic biology company focused on developing novel small molecule therapeutics inspired by nature to treat central nervous system (CNS) disorders such as pain, mental…
TL;DR
Stage: Preclinical
Therapeutic focus: CNS disorders (pain, addiction, mental health)
Platform: AI-driven discovery + yeast-based biomanufacturing
Recent financing: $3.0M pre-seed (Sep 2023)
Headquarters: Lyngby / Copenhagen region, Denmark
Company Overview
Problem Domain
Central nervous system disorders including pain (chronic and neuropathic), opioid use disorder/addiction, and psychiatric disorders (schizophrenia, bipolar).
Founded
2022
Industry
Biotechnology
Tech Stack
Funding Track Record
$3,000,000
Investors listed include Amino Collective, BlueYard Capital, Nucleus Capital